Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
The oral iron chelator deferasirox inhibits NF-ΚB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemia

Banerjee A, Mifsud NA, Bird R, Forsyth C, Szer J, Tam C, Kellner S, Grigg A, Motum P, Bentley M, Opat S, Grigoriadis G

(2015), Br J Haematol, 168(4), 576-82

Antibiotic prophylaxis for endocarditis

Spelman D

(2015), In: Symons J, Myles P, Mehra R, Ball C (eds), Perioperative Medicine for the Junior Clinician, Wiley Blackwell, UK, Chapter 30,

Travel risk assessment, advice and vaccinations in immunocompromised travellers (HIV, solid organ transplant and haematopoeitic stem cell transplant recipients): a review

Aung AK, Trubiano JA, Spelman DW

(2015), Travel Med Infect Dis, 13(1), 31-47

Inappropriate pathology ordering and pathology stewardship

Spelman D

(2015), Med J Aust, 202(1), 13-5

Draft genome sequences of clinical daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus strain APS211 and its daptomycin-susceptible progenitor APS210

Cameron DR, Jiang JH, Abbott IJ, Spelman DW, Peleg AY

(2015), Genome Announc, 3(3), e00568-15

The potential complexity and need for caution when interpreting atypical human immunodeficiency virus reactivity in blood donors

Kiely P, Catton M, Brown D, Chibo D, Karapanagiotidis T, Spelman D

(2015), Blood Transfus, 13(4), 669-71

Numerous Howell-Jolly bodies in a patient with idiopathic splenic calcification

Cummins KD, Westall GP, Grigoriadis G

(2015), Br J Haematol, 169(6), 767

Active surveillance for multidrug-resistant Gram-negative bacteria in the intensive care unit

Abbott IJ, Jenney AW, Spelman DW, Pilcher DV, Sidjabat HE, Richardson LJ, Paterson DL, Peleg AY

(2015), Pathology, 47(6), 575-9

PAX5-expressing ALK-negative anaplastic large cell lymphoma with extensive extranodal and nodal involvemen

Ong DM, Cummins KD, Pham A, Grigoriadis G

(2015), BMJ Case Rep, 2015, bcr2015211159

A guide to performing cardiac surgery in patients with hereditary bleeding disorders

Bhave P, McGiffin D, Shaw J, Walsh M, McCarthy P, Tran H, Davis AK

(2015), J Card Surg, 30(1), 61-9

Optimal approach for high-risk acute promyelocytic leukemia

Iland HJ, Seymour JF, Wei A

(2014), Curr Opin Hematol, 21(2), 102-13

Laboratory detection of 'Clostridium difficile'

Dennison A

(2014), Aust J Med Sci, 35(4), 110-25

Prevalence of multidrug-resistant organisms and risk factors for carriage in long-term care facilities: a nested case-control study

Lim CJ, Cheng AC, Kennon J, Spelman D, Hale D, Melican G, Sidjabat HE, Paterson DL, Kong DC, Peleg AY

(2014), J Antimicrob Chemother, 69(7), 1972-80

Rickettsial infections in Southeast Asia: implications for local populace and febrile returned travelers

Aung AK, Spelman DW, Murray RJ, Graves S

(2014), Am J Trop Med Hyg, 91(3), 451-60

Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia

Cheah AL, Peel T, Howden BP, Spelman D, Grayson ML, Nation RL, Kong DC

(2014), BMC Infect Dis, 14, 353

A case of gonococcal necrotising fasciitis

Kanhutu KN, Spelman DD, Weymouth MD

(2014), Sex Health, 11(3), 280-2

Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients

Govindaraj C, Tan P, Walker P, Wei A, Spencer A, Plebanski M

(2014), Clin Cancer Res, 20(3), 724-35

Lenalidomide-based maintenance therapy reduces TNF receptor 2 on CD4 T cells and enhances immune effector function in acute myeloid leukemia patients

Govindaraj C, Madondo M, Kong YY, Tan P, Wei A, Plebanski M

(2014), Am J Hematol, 89(8), 795-802

Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care

Iland HJ, Wei A, Seymour JF

(2014), Best Pract Res Clin Haematol, 27(1), 39-52

Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia

Cummins KD, Jane SM, Ninkovic S, Bazargan A, Filshie R, Sutrave G, Hertzberg M, Scott A, Lane S, Yannakou CK, Ritchie D, D'Rozario J, Black J, Bavishi K, Wei A

(2014), Blood Cancer J, 4, e237

11 12 13 14 15